Hemifacial Spasm
22
2
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
18%
4 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (22)
Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm
Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict
Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients
Magnetic Resonance Imaging Study on Patients With Hemifacial Spasm
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
Transcutaneous Electrical Acupoint Stimulation on Postoperative Dizziness in Hemifacial Spasm Patients
Microvascular Decompressive Surgery for Hemifacial Spasm
Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
Post Marketing Surveillance Study of Dysport
Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm
Effect of Acupuncture on Inflammation and Immune Function After Craniotomy
Effect of Hemifacial Spasm on Intraocular Pressure Measurement
Botulinum Toxin A in the Treatment of Hemifacial Spasm
CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar Tap
Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery
Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery
A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese Patients
Hemifacial Spasm and Desflurane
Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm
Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm